Company intelligence / Profile preview

ChatGPT

San Francisco, California, United States

Ownership: Private
Employees: ~1000
Development stage: Other

Overview

OpenAI is an artificial intelligence research and deployment company that developed ChatGPT, a leading large language model. While not a traditional biotechnology company, OpenAI has become a significant player in the life sciences and healthcare sectors through strategic partnerships and the application of its generative AI models. The company's technology is utilized for drug discovery, clinical trial optimization, medical documentation, and patient support. OpenAI collaborates with major pharmaceutical firms and healthcare providers to integrate AI into research workflows and diagnostic tools.

Industry: Drug Discovery Services

Partnerships

ModernaSanofiColor HealthPwCMicrosoftSummer Health

Beyond the preview

Go deeper on ChatGPT.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on ChatGPT.

Explore the full profile